miR-126-5p targets SP1 to inhibit the progression of Parkinson's disease

YP Han, ZJ Liu, HH Bao, Q Wang, LL Su - European Neurology, 2022 - karger.com
Background: At present, symptomatic treatment may improve the life quality of Parkinson's
disease (PD) patients to a certain extent but cannot completely cure PD. Therefore, it is …
被引用次数：8 相关文章

miR-126-5p Targets SP1 to Inhibit the Progression of Parkinson's Disease.

YP Han, ZJ Liu, HH Bao, Q Wang… - European …, 2022 - search.ebscohost.com
Background: At present, symptomatic treatment may improve the life quality of Parkinson's
disease (PD) patients to a certain extent but cannot completely cure PD. Therefore, it is …

miR-126-5p Targets SP1 to Inhibit the Progression of Parkinson's Disease.

YP Han, ZJ Liu, HH Bao, Q Wang, LL Su - European Neurology, 2022 - europepmc.org
Background At present, symptomatic treatment may improve the life quality of Parkinson's
disease (PD) patients to a certain extent but cannot completely cure PD. Therefore, it is …

miR-126-5p Targets SP1 to Inhibit the Progression of Parkinson's Disease

YP Han, ZJ Liu, HH Bao, Q Wang, LL Su - European Neurology, 2022 - karger.com
Background: At present, symptomatic treatment may improve the life quality of Parkinson's
disease (PD) patients to a certain extent but cannot completely cure PD. Therefore, it is …

miR-126-5p Targets SP1 to Inhibit the Progression of Parkinson's Disease

YP Han, ZJ Liu, HH Bao, Q Wang… - European …, 2022 - pubmed.ncbi.nlm.nih.gov
Background At present, symptomatic treatment may improve the life quality of Parkinson's
disease (PD) patients to a certain extent but cannot completely cure PD. Therefore, it is …